On May 17, 2023 Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company using its proprietary RADR artificial intelligence ("AI") and machine learning ("ML") platform to transform the cost, pace, and timeline of oncology drug discovery and development, reported that Panna Sharma, CEO and President, will present at the Lytham Partners Spring 2023 Investor Conference on Thursday, May 18, 2023 (Press release, Lantern Pharma, MAY 17, 2023, View Source [SID1234631820]). The fireside chat-style webcast will be available to all registered attendees. Details of the webcast can be found below:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Lytham Partners Spring 2023 Investor Conference, Thursday, May 18th at 9:00 a.m. ET.
Presenter: Panna Sharma, CEO & President.
Webcast Link: View Source
Lantern management will also be participating in one-on-one virtual investor meetings throughout the conference. To arrange a meeting with management, please contact Lytham Partners at 1×[email protected] or register at View Source